The PPARG Pro12Ala polymorphism is associated with a decreased risk of developing hyperglycemia over 6 years and combines with the effect of the APM1 G-11391A single nucleotide polymorphism: the Data From an Epidemiological Study on the Insulin Resi
about
Genes, diet and type 2 diabetes mellitus: a reviewThe longitudinal association of common susceptibility variants for type 2 diabetes and obesity with fasting glucose level and BMI.Association of the Pro12Ala Polymorphism with the Metabolic Parameters in Women with Polycystic Ovary Syndrome.The C-681G polymorphism of the PPAR-γ gene is associated with susceptibility to non-alcoholic fatty liver disease.PPARγ2 Pro12Ala polymorphism was associated with favorable cardiometabolic risk profile in HIV/HCV coinfected patients: a cross-sectional studyVariation in PPARG is associated with longitudinal change in insulin resistance in Mexican Americans at risk for type 2 diabetes.Application of back propagation artificial neural network on genetic variants in adiponectin ADIPOQ, peroxisome proliferator-activated receptor-γ, and retinoid X receptor-α genes and type 2 diabetes risk in a Chinese Han populationGenetic associations of leptin-related polymorphisms with systemic lupus erythematosusPPAR Action in Human Placental Development and Pregnancy and Its Complications.PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular Disease.Tagging single nucleotide polymorphisms in the PPAR-γ and RXR-α gene and type 2 diabetes risk: a case-control study of a Chinese Han populationPharmacogenetics of the PPAR genes and cardiovascular disease.Distinct gene regulatory programs define the inhibitory effects of liver X receptors and PPARG on cancer cell proliferationAssociation of sirtuin 1 (SIRT1) gene SNPs and transcript expression levels with severe obesity.PPARγ2 polymorphism and human health.Association of PPARG Pro12Ala polymorphism with insulin sensitivity and body mass index in patients with polycystic ovary syndrome.Application of the back-error propagation artificial neural network (BPANN) on genetic variants in the PPAR-γ and RXR-α gene and risk of metabolic syndrome in a Chinese Han population.Associations between single-nucleotide polymorphisms (+45T>G, +276G>T, -11377C>G, -11391G>A) of adiponectin gene and type 2 diabetes mellitus: a systematic review and meta-analysis.Association of the peroxisome proliferator-activated receptor-gamma2 Pro12Ala but not the C1431T gene variants with lower body mass index in Type 2 diabetes.Dietary fat intake and polymorphisms at the PPARG locus modulate BMI and type 2 diabetes risk in the D.E.S.I.R. prospective study.Endocannabinoid receptor 1 gene variations increase risk for obesity and modulate body mass index in European populations.Gene-diet-related factors of hyperglycaemia in postmenopausal women.Impact of the PPAR gamma-2 gene polymorphisms on the metabolic state of postmenopausal women.
P2860
Q24672249-40E5A782-E1C2-48AB-8A3A-6B682CDE65ACQ33712531-92F5B873-665D-488B-AAD8-B07674E836BCQ33889546-7EC063AA-B3AA-4F25-B07F-EBD2FE6DBC08Q34019843-BC89CD3B-756D-4625-99D7-E3420FEC84C8Q34803775-A689C5C6-0B44-4A12-A1BE-92FA1D8B8523Q35096813-0EFD10A0-8EB9-44C9-B490-A40A34A81E03Q35772627-D7ADC6E3-C693-402F-83E2-36E358C343DFQ36315896-CD4311CE-92D9-4124-8545-D9AE172BC795Q36446678-42F16DEB-FE4C-41B2-B312-9BD4F262C1DFQ36528512-6D96FE5F-4150-4325-914D-F45AEC96C6BBQ36681873-A36AF934-16F6-4D19-A796-6944E86C8670Q37012017-6D259794-46EB-4993-9753-46663A1F2A07Q37084995-A8926147-9DF9-4A09-94F5-8E88227B86FBQ37139750-9F2238B0-B442-473C-8A96-AC80D69A0CE0Q37159796-48A1ECA0-77C5-4410-B0C7-D86D4A0BFDE1Q37567750-96CD8CAA-C9F7-4395-868D-140A1C3D0EE5Q37669815-F5E2AB46-2738-4F48-916B-957CA1D14083Q37884457-A446A759-4866-4B79-9B34-8D48CA141E4EQ39258427-7BF8969A-8AB4-422F-8EEA-D8216336C966Q43900723-3851EF10-5E7D-461B-8E6C-10ACE983C377Q44854376-EC5A27D9-6926-4338-8A12-753F6B50DF0DQ49721479-FF4EC779-EAF6-438D-AAF4-968052B7A548Q51539637-71821945-9A39-41BF-B14A-F6F1585B37ED
P2860
The PPARG Pro12Ala polymorphism is associated with a decreased risk of developing hyperglycemia over 6 years and combines with the effect of the APM1 G-11391A single nucleotide polymorphism: the Data From an Epidemiological Study on the Insulin Resi
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The PPARG Pro12Ala polymorphis ...... ical Study on the Insulin Resi
@ast
The PPARG Pro12Ala polymorphis ...... ical Study on the Insulin Resi
@en
type
label
The PPARG Pro12Ala polymorphis ...... ical Study on the Insulin Resi
@ast
The PPARG Pro12Ala polymorphis ...... ical Study on the Insulin Resi
@en
prefLabel
The PPARG Pro12Ala polymorphis ...... ical Study on the Insulin Resi
@ast
The PPARG Pro12Ala polymorphis ...... ical Study on the Insulin Resi
@en
P2093
P50
P1433
P1476
The PPARG Pro12Ala polymorphis ...... ical Study on the Insulin Resi
@en
P2093
DESIR Study Group
Franck Péan
Isabelle Porchay
Jean Tichet
Martine Vaxillaire
Naïma Bellili
Riphed Jaziri
Roberte Aubert
Saida Lahmidi
Stephane Lobbens
P304
P356
10.2337/DIABETES.55.04.06.DB05-0676
P407
P577
2006-04-01T00:00:00Z